Documents
Application Sponsors
NDA 209607 | PROGENICS PHARMS INC | |
Marketing Status
Application Products
001 | SOLUTION;INTRAVENOUS | 15mCi/ML | 1 | AZEDRA | IOBENGUANE I-131 |
FDA Submissions
TYPE 5; Type 5 - New Formulation or New Manufacturer | ORIG | 1 | AP | 2018-07-30 | PRIORITY |
Submissions Property Types
CDER Filings
PROGENICS PHARMS INC
cder:Array
(
[0] => Array
(
[ApplNo] => 209607
[companyName] => PROGENICS PHARMS INC
[docInserts] => ["",""]
[products] => [{"drugName":"AZEDRA","activeIngredients":"IOBENGUANE I-131","strength":"15mCi\/ML","dosageForm":"SOLUTION;INTRAVENOUS","marketingStatus":"Prescription","te":"None","rld":"Yes","rs":"Yes"}]
[labels] => [{"actionDate":"07\/30\/2018","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2018\\\/209607s000lbl.pdf\"}]","notes":""}]
[originalApprovals] => [{"actionDate":"07\/30\/2018","submission":"ORIG-1","actionType":"Approval","submissionClassification":"Type 5 - New Formulation or New Manufacturer","reviewPriority":"PRIORITY; Orphan","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2018\\\/209607s000lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2018\\\/209607Orig1s000ltr.pdf\"},{\"name\":\"Review\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/nda\\\/2018\\\/209607Orig1s000TOC.cfm\"}]","notes":">"}]
[supplements] => [{"actionDate":"07\/24\/2019","submission":"SUPPL-1","supplementCategories":"Labeling-Package Insert","inserts":"[]","notes":"> Label is not available on this site."}]
[actionDate] => 2019-07-24
)
)